Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Summit Therapeutics (SMMT) Debt Ratio (2018 - 2024)

Summit Therapeutics filings provide 6 years of Debt Ratio readings, the most recent being 0.57 for Q1 2024.

  • Quarterly Debt Ratio rose 44.19% to 0.57 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 0.57 through Mar 2024, up 44.19% year-over-year, with the annual reading at 0.49 for FY2023, 33.83% down from the prior year.
  • Debt Ratio hit 0.57 in Q1 2024 for Summit Therapeutics, up from 0.49 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.74 in Q4 2022 and bottomed at 0.0 in Q1 2020.
  • Average Debt Ratio over 4 years is 0.39, with a median of 0.41 recorded in 2023.
  • Peak annual rise in Debt Ratio hit 82.37% in 2023, while the deepest fall reached 33.83% in 2023.
  • Summit Therapeutics' Debt Ratio stood at 0.0 in 2020, then soared by 66922.33% to 0.74 in 2022, then crashed by 33.83% to 0.49 in 2023, then increased by 14.8% to 0.57 in 2024.
  • Per Business Quant, the three most recent readings for SMMT's Debt Ratio are 0.57 (Q1 2024), 0.49 (Q4 2023), and 0.42 (Q2 2023).